Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 51: 753-758, 2005. First published January 31, 2005; 10.1373/clinchem.2004.042143
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2004.042143v1
51/4/753    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steffes, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steffes, M.
Related Collections
Right arrow Laboratory Management
Right arrow General Clinical Chemistry
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2005;51:753-758.)
© 2005 American Association for Clinical Chemistry, Inc.

General Clinical Chemistry

Hemoglobin A1c Measurements over Nearly Two Decades: Sustaining Comparable Values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study

Michael Steffes1,a, Patricia Cleary2, David Goldstein3, Randie Little3, Hsiao-Mei Wiedmeyer3, Curt Rohlfing3, Jack England3, Jean Bucksa4, Maren Nowicki4 the DCCT/EDIC Research Group

1 Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN.
2 Biostatistics Center, the George Washington University, Rockville, MD.
3 Departments of Pathology and Anatomical Sciences and Child Health, University of Missouri, Columbia, MO.
4 Fairview University Medical Center, Minneapolis, MN.

aAddress correspondence to this author at: University of Minnesota, Department of Laboratory Medicine and Pathology, MMC 609, 420 Delaware St. S.E., Minneapolis, MN 55454. Fax 612-273-3489; e-mail steff001{at}umn.edu.

Background: Clinical trials require assays that provide consistent results during the course of a study. The hemoglobin A1c (HbA1c) assay, a measure of chronic glycemia, is critical to the study of diabetes control and complications.

Methods: The Diabetes Control and Complications Trial (DCCT) and its follow-up study, the Epidemiology of Diabetes Interventions and Complications (EDIC), required 20 years of consistent HbA1c results, measured by three different ion-exchange HPLC procedures. To maintain and document consistent HbA1c results measured in the DCCT and EDIC Central Biochemistry Laboratory, a backup laboratory used frozen hemolysates as long-term calibrators and a HPLC method with a single lot of Bio-Rex 70 resin.

Results: Over 20 years, long-term quality-control values have remained constant. Four studies of nondiabetic ranges produced nearly identical values [mean (SD), 5.1 (0.5)%, 4.9 (0.3)%, 5.0 (0.4)%, and 5.0 (0.3)%].

Conclusion: The overall consistency of the HbA1c assays during the 20-year course of the DCCT and EDIC has been critical in establishing the benefits of intensive therapy and in understanding the relationship between long-term glycemia and the development and progression of the complications of diabetes.




The following articles in journals at HighWire Press have cited this article:


Home page
 Diabetes CareHome page
A. D. Paterson, B. N. Rutledge, P. A. Cleary, J. M. Lachin, R. S. Crow, and for the Diabetes Control and Complications Trial/E
The Effect of Intensive Diabetes Treatment on Resting Heart Rate in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
Diabetes Care, August 1, 2007; 30(8): 2107 - 2112.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
E. Selvin, C. M. Crainiceanu, F. L. Brancati, and J. Coresh
Short-term Variability in Measures of Glycemia and Implications for the Classification of Diabetes
Arch Intern Med, July 23, 2007; 167(14): 1545 - 1551.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
The Diabetes Control and Complications Trial/Epide
Long-Term Effect of Diabetes and Its Treatment on Cognitive Function
N. Engl. J. Med., May 3, 2007; 356(18): 1842 - 1852.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. S. Kilpatrick, A. S. Rigby, and S. L. Atkin
Variability in the Relationship between Mean Plasma Glucose and HbA1c: Implications for the Assessment of Glycemic Control
Clin. Chem., May 1, 2007; 53(5): 897 - 901.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
L. Fox, M. Dontchev, K. Ruedy, R. Beck, C. Kollman, L. Messer, J. Coffey, D. Wilson, E. Doyle, W. Tamborlane, et al.
Relative Inaccuracy of the A1cNow in Children With Type 1 Diabetes
Diabetes Care, January 1, 2007; 30(1): 135 - 137.
[Full Text] [PDF]

Home page
 DiabetesHome page
P. A. Cleary, T. J. Orchard, S. Genuth, N. D. Wong, R. Detrano, J.-Y. C. Backlund, B. Zinman, A. Jacobson, W. Sun, J. M. Lachin, et al.
The Effect of Intensive Glycemic Treatment on Coronary Artery Calcification in Type 1 Diabetic Participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study
Diabetes, December 1, 2006; 55(12): 3556 - 3565.
[Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

A plea for consistency in nomenclature of the abbreviation for glycohemoglobin
Trefor N Higgins
Clinical Chemistry Online, 2 Jun 2005 [Full text]

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Association for Clinical Chemistry.